Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Klein

Showing results (21-30 of 134) with videos related to

Pageof 14
Sort By:
Clinical Pharmacology and Therapeutics|October 12, 2020
Tri-Allelic Haplotypes Determine and Differentiate Functionally Normal Allele CYP2D6*2 and Impaired Allele CYP2D6*41Ulrich M Zanger, Kyoko Momoi, Ute Hofmann, et al.
Toxicology|January 28, 2012
Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolismAlice L Crane, Kathrin Klein, Ulrich M Zanger, et al.
Frontiers in Pharmacology|September 16, 2011
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human LiverKathrin Klein, Stefan Winter, Miia Turpeinen, et al.
Toxicology Mechanisms and Methods|December 22, 2009
Impact of genetic polymorphism in relation to other factors on expression and function of human drug-metabolizing p450sUlrich M Zanger, Kathrin Klein, Tanja Richter, et al.
Scientific Reports|September 15, 2015
Lyophilization protects [FeFe]-hydrogenases against O2-induced H-cluster degradationJens Noth, Ramona Kositzki, Kathrin Klein, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|August 2, 2017
Bericht aus der Praxis/Practice Report: How to successfully establish PAL in medical education. 10 tips to succeed in PAL-based courses in undergraduate medical education (UGME)Matthias Hofer, Kathrin Klein, Bastian Malzkorn, et al.
Advances in Pharmacology (San Diego, Calif.)|May 27, 2018
Epigenetics and MicroRNAs in PharmacogeneticsUlrich M Zanger, Kathrin Klein, Nicole Kugler, et al.
Molecular Genetics and Genomics : MGG|November 9, 2007
Non-synonymous polymorphisms in the human SLCO1B1 gene: an in vitro analysis of SNP c.1929A>CAnnick Seithel, Kathrin Klein, Ulrich M Zanger, et al.
Biotechnology Journal|February 25, 2024
The choice of ultra-low attachment plates impacts primary human and primary canine hepatocyte spheroid formation, phenotypes, and functionChen Xing, Aurino Kemas, Evgeniya Mickols, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 11, 2009
A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomesMiia Turpeinen, Ute Hofmann, Kathrin Klein, et al.
Pageof 14

Showing results (21-30 of 134) with videos related to

Sort By:
Pageof 14
Clinical Pharmacology and Therapeutics|October 12, 2020
Tri-Allelic Haplotypes Determine and Differentiate Functionally Normal Allele CYP2D6*2 and Impaired Allele CYP2D6*41Ulrich M Zanger, Kyoko Momoi, Ute Hofmann, et al.
Toxicology|January 28, 2012
Effect of CYP2B6*6 and CYP2C19*2 genotype on chlorpyrifos metabolismAlice L Crane, Kathrin Klein, Ulrich M Zanger, et al.
Frontiers in Pharmacology|September 16, 2011
Pathway-Targeted Pharmacogenomics of CYP1A2 in Human LiverKathrin Klein, Stefan Winter, Miia Turpeinen, et al.
Toxicology Mechanisms and Methods|December 22, 2009
Impact of genetic polymorphism in relation to other factors on expression and function of human drug-metabolizing p450sUlrich M Zanger, Kathrin Klein, Tanja Richter, et al.
Scientific Reports|September 15, 2015
Lyophilization protects [FeFe]-hydrogenases against O2-induced H-cluster degradationJens Noth, Ramona Kositzki, Kathrin Klein, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|August 2, 2017
Bericht aus der Praxis/Practice Report: How to successfully establish PAL in medical education. 10 tips to succeed in PAL-based courses in undergraduate medical education (UGME)Matthias Hofer, Kathrin Klein, Bastian Malzkorn, et al.
Advances in Pharmacology (San Diego, Calif.)|May 27, 2018
Epigenetics and MicroRNAs in PharmacogeneticsUlrich M Zanger, Kathrin Klein, Nicole Kugler, et al.
Molecular Genetics and Genomics : MGG|November 9, 2007
Non-synonymous polymorphisms in the human SLCO1B1 gene: an in vitro analysis of SNP c.1929A>CAnnick Seithel, Kathrin Klein, Ulrich M Zanger, et al.
Biotechnology Journal|February 25, 2024
The choice of ultra-low attachment plates impacts primary human and primary canine hepatocyte spheroid formation, phenotypes, and functionChen Xing, Aurino Kemas, Evgeniya Mickols, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 11, 2009
A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomesMiia Turpeinen, Ute Hofmann, Kathrin Klein, et al.
Pageof 14